We and others have recently shown that PPARδ is overexpressed in human psoriatic as well as in murine psoriasis-like skin lesions [39], and that treatment with delphinidin, another VDR ligand, normalized the expression in a preclinical mouse model of psoriasis [30]. The gene discussed is PPARD; the disease is psoriasis.